Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul H Gordon

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Neurology and Neuroscience Reports|January 29, 2005
Advances in clinical trials for amyotrophic lateral sclerosisPaul H Gordon
The Lancet. Neurology|September 27, 2013
The murky path to drug discovery in ALS becomes clearerPaul H Gordon
CNS Drugs|December 7, 2010
Amyotrophic lateral sclerosis: pathophysiology, diagnosis and managementPaul H Gordon
Muscle & Nerve|April 22, 2009
A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosisPaul H Gordon
Aging and Disease|October 15, 2013
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsPaul H Gordon
Neurology|December 28, 2006
Minocycline-induced skin and dental pigmentationsTahseen Mozaffar, Paul H Gordon
Nature Reviews. Neurology|September 28, 2011
How can we improve clinical trials in amyotrophic lateral sclerosis?Paul H Gordon, Vincent Meininger
Handbook of Clinical Neurology|September 24, 2008
Chapter 20 Symptomatic therapy and palliative aspects of clinical carePaul H Gordon, Hiroshi Mitsumoto
Neurology|February 21, 2007
Lou Gehrig, rawhide, and 1938Melissa Lewis, Paul H Gordon
Therapeutics and Clinical Risk Management|September 8, 2012
Amyotrophic lateral sclerosis and the clinical potential of dexpramipexolePhilippe Corcia, Paul H Gordon
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Neurology and Neuroscience Reports|January 29, 2005
Advances in clinical trials for amyotrophic lateral sclerosisPaul H Gordon
The Lancet. Neurology|September 27, 2013
The murky path to drug discovery in ALS becomes clearerPaul H Gordon
CNS Drugs|December 7, 2010
Amyotrophic lateral sclerosis: pathophysiology, diagnosis and managementPaul H Gordon
Muscle & Nerve|April 22, 2009
A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosisPaul H Gordon
Aging and Disease|October 15, 2013
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsPaul H Gordon
Neurology|December 28, 2006
Minocycline-induced skin and dental pigmentationsTahseen Mozaffar, Paul H Gordon
Nature Reviews. Neurology|September 28, 2011
How can we improve clinical trials in amyotrophic lateral sclerosis?Paul H Gordon, Vincent Meininger
Handbook of Clinical Neurology|September 24, 2008
Chapter 20 Symptomatic therapy and palliative aspects of clinical carePaul H Gordon, Hiroshi Mitsumoto
Neurology|February 21, 2007
Lou Gehrig, rawhide, and 1938Melissa Lewis, Paul H Gordon
Therapeutics and Clinical Risk Management|September 8, 2012
Amyotrophic lateral sclerosis and the clinical potential of dexpramipexolePhilippe Corcia, Paul H Gordon
Pageof 7